pipette
ENEnglish

Integrated QTL mapping and CRISPR screening in pooled iPSC-derived microglia reveals genetic drivers of neurodegenerative risk

Marta Perez‐Alcantara, Sam J. Washer, Yixi Chen, Juliette Steer, Daianna González‐Padilla, Joe McWilliam, David R. Willé, Nikos Panousis, Peep Kolberg, Elena Navarro‐Guerrero, Kaur Alasoo, Hazel Hall‐Roberts, Julie H. Williams, Sally A. Cowley, Gosia Trynka, Andrew Roger Bassett

Revista con revisión por pares

En palabras de los autores

Abstract Mounting evidence implicates microglia in neurodegeneration, but linking disease-associated genetic variants to target genes and cellular phenotypes is hindered by the inaccessibility of these cells. We differentiated 261 human induced pluripotent stem cell lines into microglia-like (iMGL) cells in pools with phenotypic (differentiation, phagocytosis and migration) and single-cell transcriptomic readouts. Burden analysis of deleterious variants detected 36 genes influencing microglial phenotypes. Expression quantitative trait locus (eQTL) analysis identified 7,121 eQTL-associated genes and 79 colocalizations across four neurodegenerative disease genome-wide association studies, half of which had limited prior evidence of causality. Integration of eQTL and phenotypic associations highlighted the role of disease-relevant variants, including LRRK2 and TREM2 acting through microglial phagocytosis. A coupled CRISPR screen identified a role for TREM2 in phagocytosis and highlighted the importance of cell type in the directionality of phenotypic effects. By contextualizing variant effects within iMGLs in different inflammatory states, we provide a comprehensive framework for interpreting the function of risk loci in neurodegenerative disorders.

Resultado principalEl resumen no menciona limitaciones.

Apareció: jueves, 19 de noviembre. Nature Genetics. Revista con revisión por pares.

DOI: 10.1038/s41588-026-02843-0